Legal Representation
Attorney
Susan A. Smith
USPTO Deadlines
Next Deadline
1782 days remaining
Section 8 (6-Year) Declaration Due (Based on registration date 2024-06-18)
Due Date
June 18, 2030
Grace Period Ends
December 18, 2030
Additional deadlines exist. Contact your attorney for complete deadline information.
Application History
35 eventsDate | Code | Type | Description | Documents |
---|---|---|---|---|
Jun 18, 2024 | NRCC | E | NOTICE OF REGISTRATION CONFIRMATION EMAILED | Loading... |
Jun 18, 2024 | R.PR | A | REGISTERED-PRINCIPAL REGISTER | Loading... |
Apr 2, 2024 | NPUB | E | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | Loading... |
Apr 2, 2024 | PUBO | A | PUBLISHED FOR OPPOSITION | Loading... |
Mar 13, 2024 | NONP | E | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | Loading... |
Feb 29, 2024 | CNSA | O | APPROVED FOR PUB - PRINCIPAL REGISTER | Loading... |
Feb 14, 2024 | CRFA | I | CORRESPONDENCE RECEIVED IN LAW OFFICE | Loading... |
Feb 14, 2024 | TROA | I | TEAS RESPONSE TO OFFICE ACTION RECEIVED | Loading... |
Feb 14, 2024 | TEME | I | TEAS/EMAIL CORRESPONDENCE ENTERED | Loading... |
Feb 8, 2024 | GNRT | O | NON-FINAL ACTION E-MAILED | Loading... |
Feb 8, 2024 | GNRN | O | NOTIFICATION OF NON-FINAL ACTION E-MAILED | Loading... |
Feb 8, 2024 | CNRT | R | NON-FINAL ACTION WRITTEN | Loading... |
Feb 7, 2024 | CRFA | I | CORRESPONDENCE RECEIVED IN LAW OFFICE | Loading... |
Feb 7, 2024 | TEME | I | TEAS/EMAIL CORRESPONDENCE ENTERED | Loading... |
Feb 5, 2024 | ERSI | I | TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED | Loading... |
Feb 2, 2024 | CRFA | I | CORRESPONDENCE RECEIVED IN LAW OFFICE | Loading... |
Feb 2, 2024 | ALIE | A | ASSIGNED TO LIE | Loading... |
Feb 2, 2024 | TEME | I | TEAS/EMAIL CORRESPONDENCE ENTERED | Loading... |
Feb 2, 2024 | GNS3 | O | NOTIFICATION OF LETTER OF SUSPENSION E-MAILED | Loading... |
Feb 2, 2024 | GNSL | S | LETTER OF SUSPENSION E-MAILED | Loading... |
Feb 2, 2024 | CNSL | R | SUSPENSION LETTER WRITTEN | Loading... |
Jan 22, 2024 | EWAF | I | TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS | Loading... |
Jan 22, 2024 | REAP | I | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | Loading... |
Jan 22, 2024 | TCCA | I | TEAS CHANGE OF CORRESPONDENCE RECEIVED | Loading... |
Jan 22, 2024 | ARAA | I | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | Loading... |
Sep 13, 2023 | ERSI | I | TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED | Loading... |
Jul 6, 2023 | GNS2 | O | NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED | Loading... |
Jul 6, 2023 | GNSI | S | INQUIRY TO SUSPENSION E-MAILED | Loading... |
Jul 6, 2023 | CNSI | R | SUSPENSION INQUIRY WRITTEN | Loading... |
Jan 5, 2023 | GNSL | F | LETTER OF SUSPENSION E-MAILED | Loading... |
Jan 5, 2023 | GNS3 | O | NOTIFICATION OF LETTER OF SUSPENSION E-MAILED | Loading... |
Jan 5, 2023 | CNSL | R | SUSPENSION LETTER WRITTEN | Loading... |
Dec 30, 2022 | DOCK | D | ASSIGNED TO EXAMINER | Loading... |
Sep 27, 2022 | NWOS | I | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | Loading... |
Sep 15, 2022 | NWAP | I | NEW APPLICATION ENTERED | Loading... |
Detailed Classifications
Class 042
Research and development relating to drug substance and drug products for the pharmaceutical, biotech and vaccine sectors; evaluation relating to drug substance and drug products for the pharmaceutical, biotech and vaccine sectors; consultancy relating to drug substance and drug products for the pharmaceutical, biotech and vaccine sectors; testing relating to drug substance and drug products for the pharmaceutical, biotech and vaccine sectors; research and development of pharmaceutical, biotech and vaccine products; consultancy relating to pharmaceutical, biotech and vaccine sectors; advisory services relating to research and development of pharmaceutical, biotech and vaccine products
Classification
International Classes
042